Simultaneous determination of luteolin and apigenin in dog plasma by RP-HPLC

被引:59
作者
Li, LP [1 ]
Jiang, HD [1 ]
Wu, HH [1 ]
Zeng, S [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmaceut Anal & Drug Metab, Hangzhou 310031, Peoples R China
关键词
Chrysanthemum morifolium extract; luteolin; apigenin; HPLC analysis;
D O I
10.1016/j.jpba.2004.11.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A specific and accurate high-performance liquid chromatographic method has been developed and validated for the simultaneous determination of luteolin and apigenin in the plasma of dog. The sample was treated with 6.0% perchloric acid to precipitate the protein. Luteolin and apigenin were extracted with ethyl acetate. The organic layer separated was dried and reconstituted in the mobile phase. The HPLC separation was performed on C-18 column and the UV detector was set at 350 nm. The standard curve for luteolin and apigenin in plasma were linear over the range of 38.5-4350 and 16.5-1860 ng/ml, with the correlation coefficients 0.9996 and 0.9999, respectively. The assay recoveries for luteolin and apigenin ranged from 102.7 to 104.5% and 93.8-101.8%, respectively. The intra- and inter-day precisions (R.S.D.) for luteolin and apigenin were all less than 7.9%. The sample was stable within 24h at 4 degrees C storage, 30 days at -20 degrees C storage, and undergoing four freeze-thaw-assay cycles. The limits of detection (LOD) of luteolin and apigenin were 1.82 and 1.94 ng/ml, while the limits of quantification (LOQ) were 7.84 and 6.29 ng/ml, respectively. The method developed was applied successfully to study pharmacokinetics of the effective composition (luteolin) of Chrysanthemum morifolium extract in dogs after single dose of oral administration. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 15 条
[1]   Extensive binding of the bioflavonoid quercetin to human plasma proteins [J].
Boulton, DW ;
Walle, UK ;
Walle, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (02) :243-249
[2]   Synthesis and biological evaluation of flavonoids as vasorelaxant agents [J].
Chen, ZW ;
Hu, YZ ;
Wu, HH ;
Jiang, HD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) :3949-3952
[3]  
Dai M., 2001, J CHIN MED MAT, V24, P505
[4]   Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity [J].
Day, AJ ;
DuPont, MS ;
Ridley, S ;
Rhodes, M ;
Rhodes, MJC ;
Morgan, MRA ;
Williamson, G .
FEBS LETTERS, 1998, 436 (01) :71-75
[5]  
Duh PD, 1999, FOOD SCI TECHNOL-LEB, V32, P269
[6]   Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver [J].
Gradolatto, A ;
Canivenc-Lavier, MC ;
Basly, JP ;
Siess, MH ;
Teyssier, C .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) :58-65
[7]  
Jiang HD, 2004, PHARMAZIE, V59, P565
[8]  
Jiang HD, 2003, CHEM J CHINESE U, V24, P2221
[9]   Analysis and pharmacokinetics of bulaquine and its major metabolite primaquine in rabbits using an LC-UV method - a pilot study [J].
Lal, J ;
Mehrotra, N ;
Gupta, RC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 32 (01) :141-150
[10]  
Liu JQ, 2001, CHINESE TRADITIONAL, V32, P308